RadNet Past Earnings Performance
Past criteria checks 1/6
RadNet's earnings have been declining at an average annual rate of -27.4%, while the Healthcare industry saw earnings growing at 4.6% annually. Revenues have been growing at an average rate of 9.5% per year. RadNet's return on equity is 3.7%, and it has net margins of 0.2%.
Key information
-27.4%
Earnings growth rate
-29.5%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 9.5% |
| Return on equity | 3.7% |
| Net Margin | 0.2% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?
Apr 08
RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues
Mar 06Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching
Feb 08RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation
Jan 28Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult
Dec 28We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt
Dec 04RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively
Aug 27RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt
Aug 09We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt
Mar 30RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends
Feb 19RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet
Dec 12An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued
Nov 26RadNet JV acquires Montclair Radiology's outpatient radiology assets
Oct 11Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital
Oct 10RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha
Aug 28Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden
Aug 12RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance
Aug 09RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return
Jul 01Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?
Jun 17Is RadNet (NASDAQ:RDNT) A Risky Investment?
May 11Estimating The Intrinsic Value Of RadNet, Inc. (NASDAQ:RDNT)
Apr 06Is RadNet (NASDAQ:RDNT) Using Too Much Debt?
Jan 24Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled
Dec 23Is RadNet, Inc. (NASDAQ:RDNT) Potentially Undervalued?
Dec 08RadNet, Inc.'s (NASDAQ:RDNT) Intrinsic Value Is Potentially 35% Above Its Share Price
Nov 23RadNet (NASDAQ:RDNT) Has A Pretty Healthy Balance Sheet
Oct 22RadNet: An Essential Healthcare Services Stock Seen Underpriced By Market-Makers
Sep 03Returns At RadNet (NASDAQ:RDNT) Appear To Be Weighed Down
Sep 01Revenue & Expenses BreakdownBeta
How RadNet makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,617 | 3 | 142 | 0 |
| 30 Sep 23 | 1,580 | 4 | 120 | 0 |
| 30 Jun 23 | 1,528 | -13 | 121 | 0 |
| 31 Mar 23 | 1,479 | -13 | 123 | 0 |
| 31 Dec 22 | 1,430 | 11 | 144 | 0 |
| 30 Sep 22 | 1,382 | 8 | 92 | 0 |
| 30 Jun 22 | 1,365 | 23 | 61 | 0 |
| 31 Mar 22 | 1,344 | 18 | 0 | 0 |
| 31 Dec 21 | 1,324 | 25 | 0 | 0 |
| 30 Sep 21 | 1,297 | 35 | 108 | 0 |
| 30 Jun 21 | 1,256 | 24 | 55 | 0 |
| 31 Mar 21 | 1,138 | 11 | 81 | 0 |
| 31 Dec 20 | 1,098 | -15 | 0 | 0 |
| 30 Sep 20 | 1,090 | -10 | 106 | 0 |
| 30 Jun 20 | 1,091 | -13 | 108 | 0 |
| 31 Mar 20 | 1,164 | 2 | 133 | 0 |
| 31 Dec 19 | 1,154 | 15 | 0 | 0 |
| 30 Sep 19 | 1,111 | 33 | 24 | 0 |
| 30 Jun 19 | 1,060 | 35 | 99 | 0 |
| 31 Mar 19 | 1,015 | 36 | 90 | 0 |
| 31 Dec 18 | 975 | 32 | 0 | 0 |
| 30 Sep 18 | 953 | -4 | 85 | 0 |
| 30 Jun 18 | 939 | -6 | 83 | 0 |
| 31 Mar 18 | 925 | -6 | 59 | 0 |
| 31 Dec 17 | 922 | 0 | 0 | 0 |
| 30 Sep 17 | 912 | 11 | 77 | 0 |
| 30 Jun 17 | 909 | 9 | 74 | 0 |
| 31 Mar 17 | 897 | 7 | 75 | 0 |
| 31 Dec 16 | 885 | 7 | 74 | 0 |
| 30 Sep 16 | 875 | 5 | 75 | 0 |
| 30 Jun 16 | 859 | 11 | 76 | 0 |
| 31 Mar 16 | 845 | 11 | 74 | 0 |
| 31 Dec 15 | 810 | 8 | 72 | 0 |
| 30 Sep 15 | 779 | 11 | 70 | 0 |
| 30 Jun 15 | 755 | 7 | 68 | 0 |
| 31 Mar 15 | 730 | 9 | 66 | 0 |
| 31 Dec 14 | 718 | 1 | 64 | 0 |
| 30 Sep 14 | 710 | -2 | 63 | 0 |
| 30 Jun 14 | 701 | -7 | 63 | 0 |
| 31 Mar 14 | 699 | -9 | 64 | 0 |
| 31 Dec 13 | 703 | 2 | 65 | 0 |
| 30 Sep 13 | 684 | 53 | 65 | 0 |
| 30 Jun 13 | 669 | 58 | 63 | 0 |
Quality Earnings: RDNT has high quality earnings.
Growing Profit Margin: RDNT's current net profit margins (0.2%) are lower than last year (0.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RDNT's earnings have declined by 27.4% per year over the past 5 years.
Accelerating Growth: RDNT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: RDNT had negative earnings growth (-71.4%) over the past year, making it difficult to compare to the Healthcare industry average (12.5%).
Return on Equity
High ROE: RDNT's Return on Equity (3.7%) is considered low.